Cite

HARVARD Citation

    Gowin, K. et al. (n.d.). Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis. Leukemia research. pp. 31-35. [Online]. 
  
Back to record